☆ 4.6 Article

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score

JOURNAL OF INFLAMMATION RESEARCH (2022)

Related references

Note: Only part of the references are listed.

Article Orthopedics

Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? AN INTERNATIONAL MULTICENTRE STUDY

S. Spence et al.

Summary: The modified Glasgow Prognostic Score (mGPS) is a useful tool for predicting the prognosis of soft-tissue sarcoma (STS). This retrospective multicentre cohort study demonstrated that an increased mGPS score is associated with poorer outcomes in localized STS patients. Incorporating mGPS and other biochemical blood indicators into routine diagnostic assessment of STS patients can help stratify patient prognosis and guide treatment decisions.

BONE & JOINT JOURNAL (2022)

Add to Collection

Article Orthopedics

C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases

Costantino Errani et al.

Summary: Surgical options for long bone metastases vary based on patient life expectancy, with intramedullary nail fixation being recommended for shorter life expectancies and prosthetic reconstruction for longer life expectancies. This study developed a prognostic score based on C-reactive protein and primary tumor diagnosis to predict patient survival at 12 months, which outperformed previous prognostic models in accuracy. The findings suggest that these simple variables can guide treatment decisions for patients with long bone metastases undergoing surgical intervention.

INTERNATIONAL ORTHOPAEDICS (2021)

Add to Collection

Article Oncology

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel

Keisuke Ando et al.

Summary: The high-sensitivity modified Glasgow prognostic score (Hs-mGPS) is a powerful prognostic factor for castration-resistant prostate cancer (CRPC), with risk classification using Hs-mGPS, PSA, and testosterone (TST) potentially useful in predicting prognosis for late staged CRPC patients. An elevated Hs-mGPS was shown to be an independent prognostic factor in CRPC patients treated with docetaxel therapy.

CANCERS (2021)

Add to Collection

Article Oncology

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Tomoki Nakamura et al.

Summary: The study investigated the oncological outcomes of lung metastasectomy and/or radiofrequency ablation in patients with soft tissue sarcoma. Results showed that complete treatment for the initial metastasis improved post-metastatic survival rates, with tumor size and number being important variables for clinical decision-making. Patients with a smaller single metastasis had better post-metastasis survival rates compared to those with larger and multiple metastases. The 5-year post-metastatic survival rates were higher for patients with a smaller single metastasis.

CANCER MANAGEMENT AND RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study

Andreas Eckart et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma

Tao Hou et al.

EJSO (2020)

Add to Collection

Article Multidisciplinary Sciences

The value of C-reactive protein as an independent prognostic indicator for disease specific survival in patients with soft tissue sarcoma: A meta-analysis

Xiaolin Wang et al.

PLOS ONE (2019)

Add to Collection

Article Medicine, General & Internal

Cancer-associated cachexia

Vickie E. Baracos et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Add to Collection

Article Oncology

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

Dario Callegaro et al.

LANCET ONCOLOGY (2016)

Add to Collection

Article Orthopedics

The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma

T. Nakamura et al.

Bone & Joint Journal (2015)

Add to Collection

Review Oncology

Cancer-related inflammation and treatment effectiveness

Connie I. Diakos et al.

LANCET ONCOLOGY (2014)

Add to Collection

Article Oncology

The High-Sensitivity Modified Glasgow Prognostic Score Is Superior to the Modified Glasgow Prognostic Score as a Prognostic Predictor in Patients with Resectable Gastric Cancer

Shinsuke Takeno et al.

ONCOLOGY (2014)

Add to Collection

Article Oncology

The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma

Tomoki Nakamura et al.

EUROPEAN JOURNAL OF CANCER (2013)

Add to Collection

Article Oncology

Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma

Tomoki Nakamura et al.

CANCER (2012)

Add to Collection

Article Gastroenterology & Hepatology

Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer

Donald C. McMillan et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)

Add to Collection

Review Medicine, General & Internal

Medical progress: Soft-tissue sarcomas in adults

MA Clark et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Oncology

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

LM Forrest et al.

BRITISH JOURNAL OF CANCER (2003)

Add to Collection

Article Oncology

Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss

DC McMillan et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.